Found: 49
Select item for more details and to access through your institution.
Reply from the authors.
- Published in:
- Hepatology Research, 2020, v. 50, n. 12, p. 1393, doi. 10.1111/hepr.13578
- By:
- Publication type:
- Article
Impact of viral eradication by direct‐acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus‐related compensated cirrhosis patients.
- Published in:
- Hepatology Research, 2020, v. 50, n. 11, p. 1222, doi. 10.1111/hepr.13554
- By:
- Publication type:
- Article
Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 251, doi. 10.1159/000528145
- By:
- Publication type:
- Article
Pathological Complete Response to Lenvatinib after Failure of Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Hepatitis B Virus (HBV) Upregulates TRAIL-R3 Expression in Hepatocytes Resulting in Escape From Both Cell Apoptosis and Suppression of HBV Replication by TRAIL.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 5, p. 686, doi. 10.1093/infdis/jiac044
- By:
- Publication type:
- Article
Signal Activation of Hepatitis B Virus-Related Hepatocarcinogenesis by Up-regulation of SUV39h1.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Conversion from Positive to Negative EGFR Mutation due to Clonal Selection during Long-Term Treatment with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Case Report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
A Case of Gingival Metastasis from Rectal Cancer in Which Immunohistochemistry and PET-CT Were Useful for the Diagnostic Procedure.
- Published in:
- Case Reports in Oncology, 2014, v. 7, n. 1, p. 246, doi. 10.1159/000362185
- By:
- Publication type:
- Article
The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0262675
- By:
- Publication type:
- Article
Concurrent Mutations in STK11 and KEAP1 Cause Treatment Resistance in KRAS Wild-type Non-small-cell Lung Cancer.
- Published in:
- Internal Medicine, 2023, v. 62, n. 20, p. 3001, doi. 10.2169/internalmedicine.1110-22
- By:
- Publication type:
- Article
Successful Lenvatinib Re-challenge following Atezolizumab Plus Bevacizumab Combination Therapy Failure for Unresectable Hepatocellular Carcinoma.
- Published in:
- Internal Medicine, 2023, v. 62, n. 12, p. 1771, doi. 10.2169/internalmedicine.9581-22
- By:
- Publication type:
- Article
Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Incidence of microsatellite instability‐high hepatocellular carcinoma among Japanese patients and response to pembrolizumab.
- Published in:
- Hepatology Research, 2020, v. 50, n. 7, p. 885, doi. 10.1111/hepr.13496
- By:
- Publication type:
- Article
The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib.
- Published in:
- Oncology, 2023, v. 101, n. 8, p. 491, doi. 10.1159/000530991
- By:
- Publication type:
- Article
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
- Published in:
- Oncology, 2021, v. 99, n. 8, p. 507, doi. 10.1159/000515865
- By:
- Publication type:
- Article
Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology, 2021, v. 99, n. 8, p. 491, doi. 10.1159/000515280
- By:
- Publication type:
- Article
Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy.
- Published in:
- Oncology, 2021, v. 99, n. 5, p. 327, doi. 10.1159/000514315
- By:
- Publication type:
- Article
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib.
- Published in:
- Oncology, 2020, v. 98, n. 11, p. 787, doi. 10.1159/000509387
- By:
- Publication type:
- Article
Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib.
- Published in:
- Oncology, 2019, v. 97, n. 2, p. 75, doi. 10.1159/000499715
- By:
- Publication type:
- Article
Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 9, p. 1304, doi. 10.1111/jvh.13557
- By:
- Publication type:
- Article
Abatacept treatment for patients with severe acute hepatitis caused by hepatitis B virus infection—Pilot study.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 2, p. 400, doi. 10.1111/jvh.13441
- By:
- Publication type:
- Article
Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02016-3
- By:
- Publication type:
- Article
Hepatic venous pressure gradient after balloon-occluded retrograde transvenous obliteration and liver stiffness measurement predict the prognosis of patients with gastric varices.
- Published in:
- BMC Gastroenterology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12876-022-02616-z
- By:
- Publication type:
- Article
Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study).
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1223, doi. 10.1007/s10147-019-01473-3
- By:
- Publication type:
- Article
Bleomycin-induced pulmonary fibrosis after tumor lysis syndrome in a case of advanced yolk sac tumor treated with bleomycin, etoposide and cisplatin (BEP) chemotherapy.
- Published in:
- 2012
- By:
- Publication type:
- Report
Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-48045-z
- By:
- Publication type:
- Article
Benign Recurrent Intrahepatic Cholestasis Type 1 with Novel Nonsense Mutations in the ATP8B1 Gene.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Correlation between serum pro‐inflammatory cytokine levels and the prognosis of the patients with acute liver failure.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 9, p. 1637, doi. 10.1111/jgh.16300
- By:
- Publication type:
- Article
Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 3, p. 592, doi. 10.1111/jgh.15766
- By:
- Publication type:
- Article
Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 6, p. 1685, doi. 10.1111/jgh.15377
- By:
- Publication type:
- Article
Risk factors for histological progression of non‐alcoholic steatohepatitis analyzed from repeated biopsy cases.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 8, p. 1412, doi. 10.1111/jgh.14968
- By:
- Publication type:
- Article
Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920922051
- By:
- Publication type:
- Article
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.7025
- By:
- Publication type:
- Article
Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1328, doi. 10.3390/cancers16071328
- By:
- Publication type:
- Article
Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4234, doi. 10.3390/cancers15174234
- By:
- Publication type:
- Article
Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-Fetoprotein.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2304, doi. 10.3390/cancers15082304
- By:
- Publication type:
- Article
Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma—Consideration of the Locations of Target Lesions.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 846, doi. 10.3390/cancers15030846
- By:
- Publication type:
- Article
Analysis of Lenvatinib's Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5066, doi. 10.3390/cancers14205066
- By:
- Publication type:
- Article
Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 320, doi. 10.3390/cancers14020320
- By:
- Publication type:
- Article
Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 3958, doi. 10.3390/cancers13163958
- By:
- Publication type:
- Article
Calcium channel blockers improve the prognosis of patients with intrahepatic cholangiocarcinoma after resection.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric mice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2278, doi. 10.1002/ijc.34247
- By:
- Publication type:
- Article
Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study.
- Published in:
- BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02851-y
- By:
- Publication type:
- Article
Serial profiling of circulating tumor DNA for optimization of anti‐VEGF chemotherapy in metastatic colorectal cancer patients.
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 7, p. 1418, doi. 10.1002/ijc.31154
- By:
- Publication type:
- Article
In vitro analysis of hepatic stellate cell activation influenced by transmembrane 6 superfamily 2 polymorphism.
- Published in:
- Molecular Medicine Reports, 2021, v. 23, n. 1, p. N.PAG
- By:
- Publication type:
- Article